Company intelligence / Profile preview
Vectans Pharma
Francevectanspharma.com ↗
- Ownership
- Private
- Employees
- ~49
- Development stage
- Commercial
01
Overview
Vectans Pharma specializes in optimizing existing treatments and developing novel therapeutics for unmet medical needs, particularly within oral pathology. Its proprietary Lauriad® technology enables targeted delivery via mucoadhesive buccal tablets. The company has commercialized at least two "best-in-disease" products across major global markets and continues to expand its pipeline with additional programs focused on anti-infectives and supportive care.
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- Mucoadhesive buccal tablet technology (Lauriad®)
- Industry
- Biotech
02
Drug pipeline
19 assets18 more assets in the full pipeline.
Beyond the preview
Go deeper on Vectans Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vectans Pharma.